These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33009381)

  • 21. Generation of human bispecific common light chain antibodies by combining animal immunization and yeast display.
    Krah S; Schröter C; Eller C; Rhiel L; Rasche N; Beck J; Sellmann C; Günther R; Toleikis L; Hock B; Kolmar H; Becker S
    Protein Eng Des Sel; 2017 Apr; 30(4):291-301. PubMed ID: 28062646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid Purification of Human Bispecific Antibodies via Selective Modulation of Protein A Binding.
    Zwolak A; Leettola CN; Tam SH; Goulet DR; Derebe MG; Pardinas JR; Zheng S; Decker R; Emmell E; Chiu ML
    Sci Rep; 2017 Nov; 7(1):15521. PubMed ID: 29138497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient generation of bispecific IgG antibodies by split intein mediated protein trans-splicing system.
    Han L; Chen J; Ding K; Zong H; Xie Y; Jiang H; Zhang B; Lu H; Yin W; Gilly J; Zhu J
    Sci Rep; 2017 Aug; 7(1):8360. PubMed ID: 28827777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excellent removal of knob-into-hole bispecific antibody byproducts and impurities in a single-capture chromatography.
    Chen SW; Hoi KM; Mahfut FB; Yang Y; Zhang W
    Bioresour Bioprocess; 2022 Jul; 9(1):72. PubMed ID: 38647639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and Validation of a Novel Generic Platform for the Production of Tetravalent IgG1-like Bispecific Antibodies.
    Golay J; Choblet S; Iwaszkiewicz J; Cérutti P; Ozil A; Loisel S; Pugnière M; Ubiali G; Zoete V; Michielin O; Berthou C; Kadouche J; Mach JP; Duonor-Cérutti M
    J Immunol; 2016 Apr; 196(7):3199-211. PubMed ID: 26921308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Characterization of Different Molecular Formats of Bispecific Antibodies Targeting EGFR and PD-L1.
    Mohan N; Agrawal A; Shen Y; Winarski KL; Endo Y; Dokmanovic M; Schmiel D; Zheng J; Rotstein DS; Pelosof LC; Wu WJ
    Pharmaceutics; 2022 Jun; 14(7):. PubMed ID: 35890277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intein mediated high throughput screening for bispecific antibodies.
    Hofmann T; Schmidt J; Ciesielski E; Becker S; Rysiok T; Schütte M; Toleikis L; Kolmar H; Doerner A
    MAbs; 2020; 12(1):1731938. PubMed ID: 32151188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity.
    Tustian AD; Endicott C; Adams B; Mattila J; Bak H
    MAbs; 2016; 8(4):828-38. PubMed ID: 26963837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization and Monitoring of a Novel Light-heavy-light Chain Mispair in a Therapeutic Bispecific Antibody.
    Cao M; Parthemore C; Jiao Y; Korman S; Aspelund M; Hunter A; Kilby G; Chen X
    J Pharm Sci; 2021 Aug; 110(8):2904-2915. PubMed ID: 33894207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Removing a difficult-to-separate byproduct by Capto L affinity chromatography during the purification of a WuXiBody-based bispecific antibody.
    Wang Y; Chen X; Wang Y; Li Y
    Protein Expr Purif; 2020 Nov; 175():105713. PubMed ID: 32738439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanocell targeting using engineered bispecific antibodies.
    Taylor K; Howard CB; Jones ML; Sedliarou I; MacDiarmid J; Brahmbhatt H; Munro TP; Mahler SM
    MAbs; 2015; 7(1):53-65. PubMed ID: 25523746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sheathless CE-MS as a tool for monitoring exchange efficiency and stability of bispecific antibodies.
    Gstöttner C; Vergoossen DLE; Wuhrer M; Huijbers MGM; Domínguez-Vega E
    Electrophoresis; 2021 Jan; 42(1-2):171-176. PubMed ID: 32901958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new approach for generating bispecific antibodies based on a common light chain format and the stable architecture of human immunoglobulin G
    De Nardis C; Hendriks LJA; Poirier E; Arvinte T; Gros P; Bakker ABH; de Kruif J
    J Biol Chem; 2017 Sep; 292(35):14706-14717. PubMed ID: 28655766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cysteine-SILAC Mass Spectrometry Enabling the Identification and Quantitation of Scrambled Interchain Disulfide Bonds: Preservation of Native Heavy-Light Chain Pairing in Bispecific IgGs Generated by Controlled Fab-arm Exchange.
    van den Bremer ETJ; Labrijn AF; van den Boogaard R; Priem P; Scheffler K; Melis JPM; Schuurman J; Parren PWHI; de Jong RN
    Anal Chem; 2017 Oct; 89(20):10873-10882. PubMed ID: 28922593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guiding bispecific monovalent antibody formation through proteolysis of IgG1 single-chain.
    Dimasi N; Fleming R; Sachsenmeier KF; Bezabeh B; Hay C; Wu J; Sult E; Rajan S; Zhuang L; Cariuk P; Buchanan A; Bowen MA; Wu H; Gao C
    MAbs; 2017 Apr; 9(3):438-454. PubMed ID: 28055299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of the Fc fusion format to generate tag-free bi-specific diabodies.
    Asano R; Ikoma K; Kawaguchi H; Ishiyama Y; Nakanishi T; Umetsu M; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I
    FEBS J; 2010 Jan; 277(2):477-87. PubMed ID: 20015073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of dual-variable-domain immunoglobulin molecules for dual-specific targeting.
    Gu J; Ghayur T
    Methods Enzymol; 2012; 502():25-41. PubMed ID: 22208980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bi-specific antibodies with high antigen-binding affinity identified by flow cytometry.
    Xu L; Zhang Y; Wang Q; Zhao J; Liu M; Guo M; Jiang Y; Cao H; Li Q; Ren G; Li D
    Int Immunopharmacol; 2015 Feb; 24(2):463-473. PubMed ID: 25526913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prodrug-Activating Chain Exchange (PACE) converts targeted prodrug derivatives to functional bi- or multispecific antibodies.
    Dickopf S; Buldun C; Vasic V; Georges G; Hage C; Mayer K; Forster M; Wessels U; Stubenrauch KG; Benz J; Ehler A; Lauer ME; Ringler P; Kobold S; Endres S; Klein C; Brinkmann U
    Biol Chem; 2022 Apr; 403(5-6):495-508. PubMed ID: 35073465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fab-Arm Exchange Combined with Selective Protein A Purification Results in a Platform for Rapid Preparation of Monovalent Bispecific Antibodies Directly from Culture Media.
    Steinhardt J; Wu Y; Fleming R; Ruddle BT; Patel P; Wu H; Gao C; Dimasi N
    Pharmaceutics; 2019 Dec; 12(1):. PubMed ID: 31861347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.